What We're Reading: Page 106
Industry reads hand-picked by our editors
Apr 04, 2023
-
The Wall Street Journal
Mounjaro Could Eclipse Ozempic as the Most Powerful Weight-Loss Drug
-
Reuters
Arbutus files patent infringement lawsuit against Pfizer/BioNTech over COVID shots
-
Fierce Biotech
Gossamer halts work on BTK inhibitor after 2 patient deaths
-
Bloomberg
Adderall, Xanax Are Hard to Get Because of the Opioid Crisis
Apr 03, 2023
Mar 31, 2023
Mar 30, 2023
-
Science
Promising Alzheimer’s therapy and related drugs shrink brains
-
Politico
Lawmakers press FDA on clinical trial holds
-
The New York Times
AstraZeneca’s Covid Vaccine May Have Posed a Higher Heart Risk for Young Women, Study Shows
-
Bloomberg Law
Biogen Dodges Investor Suit on Failed Alzheimer’s Drug Rollout
Mar 29, 2023
Mar 28, 2023
Mar 27, 2023
-
Reuters
Cash-rich BioNTech plans to spend about $1 bln more on research this year
-
Stat News
Why the world’s smallest wheelchairs are going unused
-
MedCity News
FDA Approval Makes Pharming Drug First for Rare Inherited Immune Disease
-
ProPublica
How Cigna Saves Millions by Having Its Doctors Reject Claims Without Reading Them
Previous
